Multiple endocrine neoplasia

Journal of Internal Medicine

Volumn 253, Issue 6, 2003, Pages 588-589

  Teh, Bin Tean ^a,b  

^a VAN ANDEL INSTITUTE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

CONFERENCE PAPER; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS DISEASE; JAW TUMOR; MOLECULAR CLONING; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA;

ACROMEGALY; HUMANS; HYPERPARATHYROIDISM; JAW NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0037681616     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01162.x     Document Type: Conference Paper

References (4)

1. McKeeby JL, Li X, Vortmeyer AO et al. Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1. Am J Pathol 2001; 159: 1121-7.
2. Verges B, Boureille F, Goudet P et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002; 87: 457-65.
3. Teh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med 1998; 243: 501-5.
4. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000; 20: 6147-58.